Effect of Refnot on Immunity in Cancer Patients
Clinical trial NCT05898451 · COMPLETED
Trial details
- NCT number
- NCT05898451
- Sponsor
- Refnot-Pharm Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-04
- Primary completion
- 2011-11-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.